Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

SELL
$0.42 - $1.48 $334,740 - $1.18 Million
-797,000 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$1.06 - $2.68 $90,100 - $227,800
-85,000 Reduced 9.64%
797,000 $917,000
Q4 2021

Feb 08, 2022

SELL
$2.5 - $5.19 $2.08 Million - $4.32 Million
-832,500 Reduced 48.56%
882,000 $2.21 Million
Q3 2021

Nov 12, 2021

BUY
$4.82 - $8.46 $3.11 Million - $5.46 Million
645,600 Added 60.4%
1,714,500 $8.78 Million
Q2 2021

Aug 16, 2021

BUY
$6.81 - $9.71 $1.51 Million - $2.15 Million
221,500 Added 26.14%
1,068,900 $8.88 Million
Q1 2021

May 12, 2021

BUY
$7.45 - $12.32 $644,425 - $1.07 Million
86,500 Added 11.37%
847,400 $7.38 Million
Q4 2020

Feb 12, 2021

BUY
$10.34 - $13.77 $3.14 Million - $4.19 Million
303,996 Added 66.53%
760,900 $8.26 Million
Q3 2020

Nov 03, 2020

BUY
$11.73 - $16.25 $5.36 Million - $7.42 Million
456,904 New
456,904 $5.45 Million

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.